Pharma & Biomedical

Identity-Led Security for Controlled Research Environments.

Biomedical and pharmaceutical facilities depend on clearly governed movement between public, operational and controlled areas. SHINE aligns access, visitors, video and alarms around the way people actually enter, move through and support the facility.

Operational priorities

Designed Around the Moments that Carry the Most Risk.

Controlled environments supported by identity-led access, visitor governance and traceable operational processes.

  1. 01

    Separate public, staff, contractor and controlled-area circulation

  2. 02

    Support traceable access into sensitive rooms and laboratories

  3. 03

    Coordinate visitor approval, escort and expiry workflows

  4. 04

    Maintain clear handover records for security operations and support teams

Integrated operating layers

One Environment. Multiple Connected Security Layers.

Select a layer to see how systems can align with the way the site operates.

Biomedical facility reception and controlled visitor arrival path
Selected layer

Visitor Arrival

Pre-registration, identification and host approval can establish a controlled path before access is issued.

  • Visitor management
  • Credential issuance
  • Host notifications

Typical project conversations

Start with the Operating Need, then Shape the System.

These are common starting points for planning. Final scope depends on the site, risk priorities, existing platforms and approval requirements.

01

Controlled-Area Access Review

Map people, roles and approval paths before selecting credentials or biometric controls.

02

Visitor & Contractor Workflow

Connect registration, host approval, temporary credentials and expiry into one practical process.

03

Laboratory Security Upgrade

Integrate access, video and alarms around sensitive rooms without interrupting core operations.

Delivery focus

Plan the Work Around the Live Environment.

Works in controlled facilities require careful coordination of access, site rules, testing windows and documentation. Method statements and handover evidence should be planned as part of the solution, not added at the end.

See how SHINE delivers

Start a conversation

Planning Security for Pharma & Biomedical?

Share the site context, operating constraints and current systems. We will help structure the next conversation.

Talk to Our Team